Table 3.
Profile | No symptoms | Few, mixed symptoms | Headache | MS | GI | Fatigue | Pulmonary | MS + GS | MS + GI + GS | All symptoms |
---|---|---|---|---|---|---|---|---|---|---|
Age | ||||||||||
OR, per year | 1 | 1.14 | 0.92 | 1.03 | 0.98 | 0.97 | 1.05 | 1.04 | 1.02 | 1.03 |
(95% CI) | (Ref.) | (1.11–1.16) | (0.91–0.93) | (1.03–1.04) | (0.97–0.99) | (0.96–0.98) | (1.04–1.06) | (1.03–1.04) | (1.01–1.03) | (1.02–1.05) |
Sex | ||||||||||
Women vs men, OR | 1 | 0.9 | 7.3 | 1.8 | 2.6 | 2.0 | 0.7 | 2.1 | 3.5 | 1.3 |
(95% CI) | (Ref.) | (1.9–2.9) | (5.1–10.3) | (1.6–2.0) | (2.1–3.2) | (1.5–2.6) | (0.6–0.9) | (1.7–2.5) | (2.6–4.8) | (0.9–1.9) |
Chronic disease | ||||||||||
Musculoskeletal, OR | 1 | 8.8 | 0.9 | 48.9 | 1.5 | 1.2 | 3.2 | 17.5 | 9.5 | 11.5 |
(95% CI) | (Ref.) | (6.9–11.3) | (0.7–1.2) | (34.0–70.3) | (1.2–1.9) | (0.9–1.6) | (2.6–4.1) | (13.5–22.8) | (7.2–12.4) | (7.1–18.5) |
Cardio-metabolic, OR | 1 | 6.5 | 0.4 | 2.5 | 1.2 | 1.7 | 6.4 | 5.1 | 3.5 | 8.1 |
(95% CI) | (Ref.) | (5.3–7.9) | (0.2–0.6) | (2.2–2.8) | (1.0–1.6) | (1.2–2.3) | (5.0–8.1) | (4.2–6.1) | (2.7–4.4) | (5.3–12.3) |
Mental, OR | 1 | 5.8 | 5.2 | 3.5 | 6.8 | 24.3 | 7.7 | 19.9 | 14.1 | 33.8 |
(95% CI) | (Ref.) | (4.5–7.5) | (4.2–6.5) | (2.9–4.2) | (5.4–8.5) | (18.9–31.2) | (5.8–10.1) | (16.3–24.4) | (10.9–18.2) | (22.0–51.9) |
Pulmonary, OR | 1 | 2.7 | 1.9 | 2.2 | 1.7 | 0.7 | 39.7 | 5.2 | 4.6 | 14.7 |
(95% CI) | (Ref.) | (2.1–3.5) | (1.5–2.5) | (1.8–2.6) | (1.2–2.3) | (0.3–1.7) | (28.9–54.6) | (4.2–6.5) | (3.4–6.1) | (9.8–22.2) |
Notes: The model includes direct effects between rapid heartbeat and chest pain and between urinary incontinence and urinary retention. N=35,188–36,163. GS includes headache, tiredness, and sleeplessness.
Abbreviations: GI, gastrointestinal; GS, general symptoms; MS, musculoskeletal; OR, odds ratio; Ref., reference profile.